Activation of Innate Immunity in Nonhuman Primates Following Intraportal Administration of Adenoviral Vectors

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Gene Transfer into the Liver of Nonhuman Primates with E1-Deleted Recombinant Adenoviral Vectors: Safety of Readministration1999 · 122 citations
2. 2Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressing α 1 -Antitrypsin after Systemic Delivery1998 · 121 citations
3. 3Immune Responses to Reporter Proteins and High Viral Dose Limit Duration of Expression with Adenoviral Vectors: Comparison of E2a Wild Type and E2a Deleted Vectors1997 · 172 citations
4. 4Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons1999 · 411 citations